|
|
Construction and Identification of Recombinant Adenovirus Ad-HIF1α |
ZHOU Nian1, HU Ning1, GONG Xuan2, WANG Chang-dong3, LIAO Jun-yi1, LIANG Xi1, HUANG Wei1 |
1. The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; 2. The Out-patient Department, Chongqing ZhongShan Hospital, Chongqing 400020, China; 3. The Molecular Biochemistry and Molecular Biology Department of School of Basic Medicine, Chongqing Medical University, Chongqing 400016, China |
|
|
Abstract Objective: To construct and identify the recombinant adenovirus Ad-HIF1α. Methods: HIF1α gene coding region was amplified from EST clones by high fidelity PCR, and the PCR product were digested by restriction enzymes BamH I and Xba I and the fragment was inserted into shuttle plasmid pAdTrace-TO4 by T4 DNA ligase.The pAdtrace-HIF1α and the framework plasmid pAdEasy-1 were transfected into BJ5183 for homogenous recombination, obtaining recombinant adenovirus plasmid pAd-HIF1α. The obtained recombinant adenovirus plasmid pAd-HIF1α was digested with PacⅠ and transfected to HEK293 cells for packaging. Ad-HIF1α was obtained after repeated amplification and purification. The infection efficiency and biological activity of the Ad-HIF1α by the expression of fluorescent protein and downstream gene(VEGF) in C3H10T1/2 wore rested. Results: Recombinant adenovirus plasmid pAd-HIF1α was constructed correctly as proved by PCR and restriction analysis. Packing the HIF1α gene expression adenovirus in HEK-293, we obtained high titer recombinant adenovirus vector Ad-HIF1α after repeated freezing and thawing four times. Ad-HIF1α can infect C3H10T1/2 efficiently and promote the expression of downstream gene (VEGF). Conclusion: The recombinant adenovirus Ad-HIF1α was constructed successfully, laying the foundation for further research.
|
Received: 24 December 2013
Published: 25 March 2014
|
|
|
|
[1] Wang Y, Wan C, Deng L F, et al.The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development. The Journal of Clinical Investigation, 2007, 117(6):1616-1626. [2] Wan C, Shao J, Gilbert S R, et al.Role of HIF-1alpha in skeletal development. Ann N Y Acad Sci, 2010, 1192(3):322-326. [3] Murphy C L, Thoms B L, Vaghjiani R J, at al. HIF-mediated articular chondrocyte function: prospects for cartilage repair. Arthritis Res Ther, 2009, 11(1):213-220. [4] Kaelin W G Jr.Molecular basis of the VHL hereditary cancer syndrome.Nat Rev Cancer, 2002, 2(9):673-682. [5] Vahid R, Abbas S L, Masoud S, et al.HIF-1α Overexpression induces angiogenesis in mesenchymal stem cells. Biores Open Access, 2012, 1(4): 174–183. [6] 张煜, 于湘辉, 查晓, 等. 重组腺病毒 Ad-CMV-TK 的构建及其对 Lewis 细胞的抑制作用.中国生物制品学杂志, 2009, 22(4):331-333. Zhang Y, Yu X H, Cha X, et al. Construction of recombinant adenovirus Ad-CMV-TK and its inhibitory effect on lewis cells. Chinese Journal of Biologicals, 2009, 22(4):331-333. [7] 匡文斌, 成凤, 秦晓林, 等. 重组腺病毒 Ad5-hNK4-EGFP 的构建与鉴定. 中国生物制品学杂志, 2012, 25(6):676-681. Kuang W B, Cheng F, Qin X L, et al. Construction and identification of recombinant adenovirus Ad5-hNK4-EGFP. Chinese Journal of Biologicals, 2012, 25(6):676-681. [8] Luo J, Deng Z L, He T C, et al.A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc, 2007, 2(5):1236-1247. [9] Mali S. Delivery systems for gene therapy. Indian J Hum Genet, 2013, 19(1):3-8. [10] Lieber A, He C Y, Kirillova I, et al. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J Virol, 1996, 70(12):8944-8960. [11] Huang S, Kamihira M.Development of hybrid viral vectors for gene therapy. Biotechnol Adv, 2013, 31(2):208-223. [12] He T C, Zhou S, da Costa L T, et al. A simplified system for generating recombinant adenoviruses.Proc Natl Acad Sci U S A, 1998, 95(5):2509-2514. [13] McConnell M J, Imperiale M J. Biology of adenovirus and its use as a vector for gene therapy.Hum Gene Ther, 2004, 15(11):1022-1033. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|